This protocol is for patients with chronic fatigue syndrome (CFS/ME) who are experiencing myalgia, joint pain, muscle pain, and headache that remain inadequately controlled despite a full trial of first-line pain management.
The previous treatment line used NSAIDs (ibuprofen or naproxen) for joint and muscle pain, headaches, and fevers, and/or COX-2 inhibitors, or anticonvulsants (gabapentin or pregabalin) for nerve pain and sleep problems.
The goal of relieving joint and muscle pain, headaches, and fevers was not adequately achieved. This protocol describes the structured next step for patients who have not responded sufficiently to those agents.
At this stage, the clinical goal is relief of severe pain that has not responded to over-the-counter analgesics. The protocol involves a specific class of prescription analgesic that is reserved for the most severe cases, with strict limitations on duration of use. The full regimen — including selection criteria, alternatives, and duration guidance — is in the structured protocol.
DOI: 10.1111/bph.13702
CFS/ME patients may benefit from NSAIDs, which are commonly used to relieve pain and reduce inflammation.
They sometimes relieve frequent or severe joint and muscle pain, headaches, and fevers.
narcotic medicines (tramadol, codeine or morphine) are sometimes prescribed for pain that is not relieved by over-the-counter drugs.
Narcotics are generally reserved for the most severe cases because of the risk of addiction, and are used only for a short time.
View source ↗